Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

by Institute for Systems Biology MoscowPET scan of a human brain with Alzheimer's disease. Credit: public domainInSysBio continues to investigate the mechanisms underlying Alzheimer's disease

Updated on: April 16,2024 10

Evaluation of tau phosphorylation-related targets for Alzheimer's treatment

by Institute for Systems Biology MoscowPET scan of a human brain with Alzheimer's disease. Credit: public domainInSysBio continues to investigate the mechanisms underlying Alzheimer's disease

Updated on:April 16,2024 10

Researchers define seizure burden, developmental outcomes for STXBP1-related disorders

by Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) found that seizure patterns and response to treatment st

Updated on: June 24,2024 3

Researchers define seizure burden, developmental outcomes for STXBP1-related disorders

by Children's Hospital of PhiladelphiaCredit: Pixabay/CC0 Public DomainResearchers from Children's Hospital of Philadelphia (CHOP) found that seizure patterns and response to treatment st

Updated on:June 24,2024 3

Race of people given Alzheimer's blood tests may affect interpretation of results

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainThree experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently

Updated on: June 24,2024 7

Race of people given Alzheimer's blood tests may affect interpretation of results

by Washington University School of MedicineCredit: Unsplash/CC0 Public DomainThree experimental blood tests used to identify people in early stages of Alzheimer's disease perform differently

Updated on:June 24,2024 7

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on: March 24,2024 14

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on:March 24,2024 14

A healthy lifestyle almost halves the risk of dementia in people with type 2 diabetes

by DiabetologiaCredit: Unsplash/CC0 Public DomainA healthy lifestyle reduces the risk of dementia in those with type 2 diabetes (T2D), according to a study of hundreds of thousands of people in t

Updated on: June 24,2024 6

A healthy lifestyle almost halves the risk of dementia in people with type 2 diabetes

by DiabetologiaCredit: Unsplash/CC0 Public DomainA healthy lifestyle reduces the risk of dementia in those with type 2 diabetes (T2D), according to a study of hundreds of thousands of people in t

Updated on:June 24,2024 6

Planning can help gun owners age safely

by University of WashingtonCredit: CC0 Public DomainThe Harborview Injury Prevention & Research Center (HIPRC) has created anew online resourceto help older adults with cognitive

Updated on: June 18,2024 8

Planning can help gun owners age safely

by University of WashingtonCredit: CC0 Public DomainThe Harborview Injury Prevention & Research Center (HIPRC) has created anew online resourceto help older adults with cognitive

Updated on:June 18,2024 8

New discovery for how the brain 'tangles' in Alzheimer's disease

by University of QueenslandCredit: Dr. Juan Polanco et. al., The University of Queensland.University of Queensland researchers have discovered a new 'seeding' process in brain cells that

Updated on: April 16,2024 10

New discovery for how the brain 'tangles' in Alzheimer's disease

by University of QueenslandCredit: Dr. Juan Polanco et. al., The University of Queensland.University of Queensland researchers have discovered a new 'seeding' process in brain cells that

Updated on:April 16,2024 10

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

Updated on: August 08,2024 0

It is not clear whether new Alzheimer's drugs will make a difference at a population level, say researchers

byUniversity of CambridgeCredit: CC0 Public DomainCambridge researchers have cast doubt on whether new amyloid immunotherapy drugs will have the desired effect of significantly reducing the impa

Updated on:August 08,2024 0

New blood test for detecting Alzheimer's disease

by Lund UniversityCredit: CC0 Public DomainResearchers from Lund University, together with the Roche pharmaceutical company, have developed a method to create a new blood marker capable of detect

Updated on: June 20,2024 7

New blood test for detecting Alzheimer's disease

by Lund UniversityCredit: CC0 Public DomainResearchers from Lund University, together with the Roche pharmaceutical company, have developed a method to create a new blood marker capable of detect

Updated on:June 20,2024 7

Multiple Sclerosis vs. Reactive Arthritis: What Are the Differences?

Multiple Sclerosis vs. Reactive Arthritis: What Are the Differences?ByLana BarhumPublished on July 04, 2022Medically reviewed byDavid Ozeri, MDMultiple sclerosis (MS) and

Updated on: June 12,2024 0

Multiple Sclerosis vs. Reactive Arthritis: What Are the Differences?

Multiple Sclerosis vs. Reactive Arthritis: What Are the Differences?ByLana BarhumPublished on July 04, 2022Medically reviewed byDavid Ozeri, MDMultiple sclerosis (MS) and

Updated on:June 12,2024 0

P-glycoprotein removes Alzheimer's-associated toxin from the brain

by Southern Methodist University(A) The first frame of SMU's simulation shows amyloid-β bound to the drug binding domains of P-gp. (B) The final frame of the same simulation shows P-gp pushin

Updated on: April 01,2024 18

P-glycoprotein removes Alzheimer's-associated toxin from the brain

by Southern Methodist University(A) The first frame of SMU's simulation shows amyloid-β bound to the drug binding domains of P-gp. (B) The final frame of the same simulation shows P-gp pushin

Updated on:April 01,2024 18

Identification of potential target protein aggregates for treating Alzheimer's

by CEACredit: CC0 Public DomainThe aggregation of alpha-synuclein proteins in Parkinson's disease and tau proteins in Alzheimer's disease is intimately linked to the progression of these neuro

Updated on: June 24,2024 5

Identification of potential target protein aggregates for treating Alzheimer's

by CEACredit: CC0 Public DomainThe aggregation of alpha-synuclein proteins in Parkinson's disease and tau proteins in Alzheimer's disease is intimately linked to the progression of these neuro

Updated on:June 24,2024 5